Zanamivir for inhal

Ended Awarded

Contract number
SPE2DP22F7815
Awardee
Awarding agency
Obligated
$5,250

Award facts

Contract value 100% obligated
$5,250.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27709, USA

Award details come from SAM.gov/FPDS.

About this award

Glaxosmithkline, LLC was awarded a $5,250 firm fixed price delivery order against an unidentified contracting vehicle to provide 8509429652, zanamivir for inhalation, to the Defense Logistics Agency Troop Support Medical. The delivery order has a period of performance through April 17, 2023 and was awarded on September 27, 2022 without a set-aside designation. Glaxosmithkline will deliver the requested pharmaceutical products to the agency's location in Research Triangle Park, North Carolina to support the Defense Logistics Agency's medical supply chain initiatives.

Quick answers

Who was awarded contract SPE2DP22F7815?

SPE2DP22F7815 was awarded to Glaxosmithkline, LLC by Medical Supply Chain (Troop Support) on September 27, 2022.

How much is contract SPE2DP22F7815 worth?

The government has obligated $5,250 on SPE2DP22F7815.

Is contract SPE2DP22F7815 an order under another contract?

Yes. SPE2DP22F7815 is a delivery order under SPE2DP22D0009, an indefinite delivery contract.

Was contract SPE2DP22F7815 competed?

The extent of competition for SPE2DP22F7815 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award